Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
| SI-BONE, Inc.SIBN · Entity 2501 | Director · Chief Executive Officer | October 12, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,018 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 9,018 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
SI-BONE, Inc.
Report date October 12, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Trust | 379,256 |
Reported balance
After 2026-10-12 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-12 · Sale · Disposed 38,006 · Balance 379,256 F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 21, 2026. F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.1050, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3: Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr. F4: Shares held by The David & Laura Joint Rev Tr. |
| Common StockSEC Table I · non-derivative | Direct | 368,129 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 368,129 F5: Includes 355,697 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 21, 2026.
F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.1050, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
F3: Reflects the transfer of shares from the Reporting Person to The David & Laura Joint Rev Tr.
F4: Shares held by The David & Laura Joint Rev Tr.
F5: Includes 355,697 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Shockwave Medical, Inc.
Report date May 31, 2024 · Filed May 31, 2024
Section 16 reporting ended · disclosed 2024-05-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 1
1 source rowRow 1 · 2024-05-31 · Disposition to issuer · Disposed 1,233 · Balance 0 F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"), F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration. |
| Common StockSEC Table I · non-derivative | IndirectDavid and Laura Francis Joint Rev Trust | 0 |
Reported balance
After 2024-05-31 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-05-31 · Disposition to issuer · Disposed 3,551 · Balance 0 F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"), F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration. F3: These shares are held in a trust for the benefit of the reporting person's children. The reporting person and the reporting person's spouse are trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.59 · Expires 2029-02-01 | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-31 · Disposition to issuer · Disposed 13,690 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"),
F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration.
F3: These shares are held in a trust for the benefit of the reporting person's children. The reporting person and the reporting person's spouse are trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2021 Filed Feb 9, 2021 22:34 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 803 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-21-001009 · primarydocument.xml · derivative · entry 5 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,989 Underlying: Common Stock · 803 shares Expires 2025-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 22:34 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 803 | $33.10 | $26,579.30 |
DisclosureSEC source: 0001562180-21-001009 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,616 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.00 to $33.23, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 22:34 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 803 | $4.32 | $3,468.96 |
DisclosureSEC source: 0001562180-21-001009 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 23:53 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 600 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-21-000574 · primarydocument.xml · derivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,792 Underlying: Common Stock · 600 shares Expires 2025-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 23:53 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 600 | $33.02 | $19,812.00 |
DisclosureSEC source: 0001562180-21-000574 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,616 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.00 to $33.05, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · balance_after: Includes 121,456 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 23:53 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 600 | $4.32 | $2,592.00 |
DisclosureSEC source: 0001562180-21-000574 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 22:35 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 49,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000253 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,616 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on January 1, 2021 and will be released in quarterly installments commencing on May 15, 2021, subject to the Reporting Person's continued service through each relevant vesting date. F2 · balance_after: Includes 121,456 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 22:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 708 | $23.82 | $16,863.78 |
DisclosureSEC source: 0001562180-20-006781 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,336 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 72,176 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 22:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 919 | $23.82 | $21,889.57 |
DisclosureSEC source: 0001562180-20-006781 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,044 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 22:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 621 | $23.82 | $14,791.54 |
DisclosureSEC source: 0001562180-20-006781 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,963 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 22:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,677 | $23.82 | $39,944.30 |
DisclosureSEC source: 0001562180-20-006781 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,584 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 20:14 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,547 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-20-006006 · primarydocument.xml · derivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,392 Underlying: Common Stock · 2,547 shares Expires 2025-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 20:14 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,547 | $23.02 | $58,627.61 |
DisclosureSEC source: 0001562180-20-006006 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,261 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $23.00 to $23.06, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F3 · balance_after: Includes 80,080 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 20:14 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 2,547 | $4.32 | $11,003.04 |
DisclosureSEC source: 0001562180-20-006006 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,029 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · derivative · entry 13 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,939 Underlying: Common Stock · 8,029 shares Expires 2025-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 931 | $20.64 | $19,215.47 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 10 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,261 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.51 to $20.94, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F5 · balance_after: Includes 80,080 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 8,029 | $21.04 | $168,965.49 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 9 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,192 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 8,029 | $4.32 | $34,685.28 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 8 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,553 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · derivative · entry 12 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,968 Underlying: Common Stock · 7,553 shares Expires 2025-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,418 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · derivative · entry 11 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,277 Underlying: Common Stock · 2,418 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,418 | $21.04 | $50,885.36 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 7 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,192 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.36, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 7,553 | $21.04 | $158,948.35 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 6 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,610 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.00 to $21.36, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 2,418 | $4.68 | $11,316.24 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 5 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 7,553 | $4.32 | $32,628.96 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 433 | $20.83 | $9,019.09 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,192 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,171 | $20.83 | $24,391.11 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,625 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 494 | $20.83 | $10,289.67 |
DisclosureSEC source: 0001562180-20-005538 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,796 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,029 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-20-005407 · primarydocument.xml · derivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,521 Underlying: Common Stock · 4,029 shares Expires 2025-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on May 26, 2015, subject to Reporting Person's continued service through each relevant vesting date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 4,029 | $21.00 | $84,609.00 |
DisclosureSEC source: 0001562180-20-005407 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,290 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 86,134 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 4,029 | $4.32 | $17,405.28 |
DisclosureSEC source: 0001562180-20-005407 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 5, 2020 20:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-20-005328 · primarydocument.xml · derivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,550 Underlying: Common Stock · 4,000 shares Expires 2025-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on May 26, 2015, subject to Reporting Person's continued service through each relevant vesting date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase. Read SEC document |
| August 04, 2020 Filed Aug 5, 2020 20:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 931 | $19.25 | $17,923.33 |
DisclosureSEC source: 0001562180-20-005328 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,290 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.70, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F4 · balance_after: Includes 86,134 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 04, 2020 Filed Aug 5, 2020 20:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 4,000 | $19.32 | $77,285.60 |
DisclosureSEC source: 0001562180-20-005328 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,221 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.94, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| August 04, 2020 Filed Aug 5, 2020 20:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 4,000 | $4.32 | $17,280.00 |
DisclosureSEC source: 0001562180-20-005328 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2020 Filed Jul 22, 2020 00:34 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | GrantCommon Stock | 2,701 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-20-014012 · dp132631_4-francis.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,701 Read SEC document |
| June 19, 2020 Filed Jun 19, 2020 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,395 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-20-004611 · primarydocument.xml · derivative · entry 9 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,550 Underlying: Common Stock · 2,395 shares Expires 2025-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| June 19, 2020 Filed Jun 19, 2020 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,395 | $17.30 | $41,435.42 |
DisclosureSEC source: 0001562180-20-004611 · primarydocument.xml · nonDerivative · entry 6 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,221 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.06 to $17.41, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F4 · balance_after: Includes 86,134 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 19, 2020 Filed Jun 19, 2020 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 2,395 | $4.32 | $10,346.40 |
DisclosureSEC source: 0001562180-20-004611 · primarydocument.xml · nonDerivative · entry 5 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,158 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-20-004611 · primarydocument.xml · derivative · entry 8 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,945 Underlying: Common Stock · 5,158 shares Expires 2025-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,418 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001562180-20-004611 · primarydocument.xml · derivative · entry 7 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,695 Underlying: Common Stock · 2,418 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,418 | $17.07 | $41,268.73 |
DisclosureSEC source: 0001562180-20-004611 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,221 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.00 to $17.28, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 5,158 | $17.07 | $88,033.13 |
DisclosureSEC source: 0001562180-20-004611 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,639 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.00 to $17.28, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 5,158 | $4.32 | $22,282.56 |
DisclosureSEC source: 0001562180-20-004611 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 20:10 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 2,418 | $4.68 | $11,316.24 |
DisclosureSEC source: 0001562180-20-004611 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2020 Filed May 19, 2020 21:14 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,585 | $17.07 | $27,055.95 |
DisclosureSEC source: 0001562180-20-003739 · primarydocument.xml · nonDerivative · entry 4 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,221 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · shares: Shares purchased pursuant to the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2020. F4 · balance_after: Includes 86,134 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:14 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 494 | $16.75 | $8,274.90 |
DisclosureSEC source: 0001562180-20-003739 · primarydocument.xml · nonDerivative · entry 3 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,221 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:14 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 434 | $16.75 | $7,269.85 |
DisclosureSEC source: 0001562180-20-003739 · primarydocument.xml · nonDerivative · entry 2 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,715 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:14 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 1,754 | $16.75 | $29,380.90 |
DisclosureSEC source: 0001562180-20-003739 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,149 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 21:42 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-002755 · primarydocument.xml · nonDerivative · entry 1 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,903 F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit vest in lump sum on January 15, 2021, subject to the Reporting Person's continued service through relevant vesting date. F2 · balance_after: Includes 93,876 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 00:57 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 944 | $21.24 | $20,055.09 |
DisclosureSEC source: 0001562180-20-001422 · primarydocument.xml · nonDerivative · entry 7 FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,528 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.239 to $21.25, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Includes 90,501 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.